NanoSphere Health Sciences Inc. (NSHS.CN)

NanoSphere Health Sciences Inc. (NSHS.CN) — VMCI valuation read

Headline read on NSHS.CN: VMCI of 39/100 versus a Healthcare sector median of 50. The 12-point below-median position is what makes NanoSphere Health Sciences Inc. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on NSHS.CN: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on NSHS.CN: value (NSHS.CN trades at 19.0x earnings, 6% above the Healthcare median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of -1.7x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

NSHS.CN rose 3.0% over the trailing 7 days, with a -4.2% read on a 30-day basis.